Congenital myopathies: Diseases of the actin cytoskeleton

Journal of Pathology

Volumn 204, Issue 4, 2004, Pages 407-417

  Clarkson, Emilie ^a   Costa, Celine F ^a   Machesky, Laura M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Actin; Muscle; Myopathy; Sarcomere; Thin filament

Indexed keywords

ACTIN; ALPHA ACTIN; NEBULIN; RYANODINE RECEPTOR; TROPOMYOSIN; TROPONIN T;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CORRELATION ANALYSIS; CYTOSKELETON; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GENE IDENTIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LIFE EXPECTANCY; MUSCLE DEVELOPMENT; MUSCLE WEAKNESS; MYOPATHY; NEMALINE MYOPATHY; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOTHERAPY; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SARCOMERE; SKELETAL MUSCLE; THIN FILAMENT;

ACTINS; CYTOSKELETON; HUMANS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; PHENOTYPE; TROPOMYOSIN;

EID: 7944229031     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1648     Document Type: Review

References (60)

1. Sparrow JC, Nowak KJ, Hayley JD, et al. Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1 . Neuromuscul Disord 2003; 13: 519-531.
2. Sanoudou D, Beggs AH. Clinical and genetic heterogeneity in nemaline myopathy - a disease of skeletal muscle thin filaments. Trends Mol Med 2001; 7: 362-368.
3. Conen PE, Murphy EG, Donohue WL. Light and electron microscopic studies of 'myogranules' in a child with hypotonia and muscle weakness. Can Med Assoc J 1963; 89: 983-986.
4. Shy GM, Engel WK, Somers JE, Wanko T. Nemaline myopathy. A new congenital myopathy. Brain 1963; 86: 793-810.
5. Walton JN. Some rare congenital and metabolic myopathies. Birth Defects Orig Artic Ser 1971; 7: 2-14.
6. Goebel HH, Borchert A. Protein surplus myopathies and other rare congenital myopathies. Semin Pediatr Neurol 2002; 9: 160-170.
7. Gommans IM, Davis M, Saar K, et al. A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions. Brain 2003; 126: 1545-1551.
8. Monnier N, Romero NB, Lerale J, et al. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor. Hum Mol Genet 2000; 9: 2599-2608.
9. Monnier N, Romero NB, Lerale J, et al. Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor. Hum Mol Genet 2001; 10: 2581-2592.
10. Laporte J, Biancalana V, Tanner SM, et al. MTM1 mutations in X-linked myotubular myopathy. Hum Mutat 2000; 15 393-409.
11. Laporte J, Guiraud-Chaumeil C, Vincent MC, et al. Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center. Hum Mol Genet 1997; 6: 1505-1511.
12. Kim SA, Taylor GS, Torgersen KM, Dixon JE. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. J Biol Chem 2002; 277 4526-4531.
13. Geeves MA, Holmes KC. Structural mechanism of muscle contraction. Annu Rev Biochem 1999; 68: 687-728.
14. Holmes KC, Geeves MA. The structural basis of muscle contraction. Philos Trans R Soc London Ser B Biol Sci 2000; 355 419-431.
15. Littlefield R, Fowler VM. Defining actin filament length in striated muscle: rulers and caps or dynamic stability? Annu Rev Cell Dev Biol 1998; 14: 487-525.
16. Luther PK. Three-dimensional structure of a vertebrate muscle Z-band: implications for titin and alpha-actinin binding. J Struct Biol 2000; 129: 1-16.
17. dos Remedios CG, Chhabra D, Kekic M, et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 2003; 83: 433-473.
18. Kabsch W, Mannherz HG, Suck D, Pai EF, Holmes KC. Atomic structure of the actin: DNase I complex. Nature 1990; 347: 37-44.
19. Littlefield R, Almenar-Queralt A, Fowler VM. Actin dynamics at pointed ends regulates thin filament length in striated muscle. Nature Cell Biol 2001; 3: 544-551.
20. Pelin K, Donner K, Holmberg M, Jungbluth H, Muntoni F, Wallgren-Pettersson C. Nebulin mutations in autosomal recessive nemaline myopathy: an update. Neuromuscul Disord 2002; 12: 680-686.
21. Millevoi S, Trombitas K, Kolmerer B, et al. Characterization of nebulette and nebulin and emerging concepts of their roles for vertebrate Z-discs. J Mol Biol 1998; 282: 111-123.
22. Karpath G (ed). Structural and Molecular Basis of Skeletal Muscle Disease. ISN Neuropath Press: Uppsala, Sweden, 2002.
23. Ryan MM, Ilkovski B, Strickland CD, et al. Clinical course correlates poorly with muscle pathology in nemaline myopathy. Neurology 2003; 60: 665-673.
24. Jin JP, Brotto MA, Hossain MM, et al. Truncation by Glu180 nonsense mutation results in complete loss of slow skeletal muscle troponin T in a lethal nemaline myopathy. J Biol Chem 2003; 278 26 159-26 165.
25. Wallgren-Pettersson C, Donner K, Sewry C, et al. Mutations in the nebulin gene can cause severe congenital nemaline myopathy. Neuromuscul Disord 2002; 12: 674-679.
26. Pelin K, Hilpela P, Donner K, et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci U S A 1999; 96: 2305-2310.
27. Wallgren-Pettersson C, Laing NG. Report of the 70th ENMC International Workshop: nemaline myopathy, 11-13 June 1999, Naarden, The Netherlands. Neuromuscul Disord 2000; 10: 299-306.
28. Agrawal PB, Strickland CD, Hidgett C, et al. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations. Ann Neurol 2004; 56: 86-96.
29. Crawford K, Flick R, Close L, et al. Mice lacking skeletal muscle actin show reduced muscle strength and growth deficits and die during the neonatal period. Mol Cell Biol 2002; 22: 5887-5896.
30. Costa CF, Rommelaere H, Waterschoot D, et al. Myopathy mutations in a-skeletal muscle actin cause a range of molecular defects. J Cell Sci 2004; 117: 3367-3377.
31. Ilkovski B, Nowak KJ, Domazetovska A, et al. Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms. Hum Mol Genet 2004; 13: 1333-1343.
32. Sanoudou D, Frieden LA, Haslett JN, et al. Molecular classification of nemaline myopathies: 'nontyping' specimens exhibit unique patterns of gene expression. Neurobiol Dis 2004; 15: 590-600.
33. Sanoudou D, Haslett JN, Kho AT, et al. Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle. Proc Natl Acad Sci U S A 2003; 100: 4666-4671.
34. Marston S, Mirza M, Abdulrazzak H, Sewry C. Functional characterisation of a mutant actin (Met132Val) from a patient with nemaline myopathy. Neuromuscul Disord 2004; 14: 167-174.
35. Anthony Akkari P, Nowak KJ, Beckman K, Walker KR, Schachat F, Laing NG. Production of human skeletal alpha-actin proteins by the baculovirus expression system. Biochem Biophys Res Commun 2003; 307: 74-79.
36. Pelin K, Ridanpaa M, Donner K, et al. Refined localisation of the genes for nebulin and titin on chromosome 2q allows the assignment of nebulin as a candidate gene for autosomal recessive nemaline myopathy. Eur J Hum Genet 1997; 5: 229-234.
37. Bang ML, Mudry RE, McElhinny AS, et al. Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies. J Cell Biol 2001; 153: 413-427.
38. Marston SB, Ingwall JS, Glueck SB. Calcium, contractions, and tropomyosin Focus on 'divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins'. Physiol Genomics 2002; 9: 57-58.
39. Pittenger MF, Kazzaz JA, Helfman DM. Functional properties of non-muscle tropomyosin isoforms. Curr Opin Cell Biol 1994; 6: 96-104.
40. Lin JJ, Warren KS, Wamboldt DD, Wang T, Lin JL. Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol 1997; 170: 1-38.
41. Donner K, Ollikainen M, Ridanpaa M, et al. Mutations in the beta-tropomyosin (TPM2) gene - a rare cause of nemaline myopathy. Neuromuscul Disord 2002; 12: 151-158.
42. Wattanasirichaigoon D, Swoboda KJ, Takada F, et al. Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy. Neurology 2002; 59: 613-617.
43. Laing NG, Wilton SD, Akkari PA, et al. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nature Genet 1995; 10: 249.
44. Akkari PA, Song Y, Hitchcock-DeGregori S, Blechynden L, Laing N. Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy. Biochem Biophys Res Commun 2002; 296: 300-304.
45. Corbett MA, Robinson CS, Dunglison GF, et al. A mutation in alpha-tropomyosin(slow) affects muscle strength, maturation and hypertrophy in a mouse model for nemaline myopathy. Hum Mol Genet 2001; 10: 317-328.
46. Tan P, Briner J, Boltshauser E, et al. Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord 1999; 9: 573-579.
47. Michele DE, Albayya FP, Metzger JM. A nemaline myopathy mutation in alpha-tropomyosin causes defective regulation of striated muscle force production. J Clin Invest 1999; 104: 1575-1581.
48. Marston SB, Redwood CS. Modulation of thin filament activation by breakdown or isoform switching of thin filament proteins: physiological and pathological implications. Circ Res 2003; 93 1170-1178.
49. Perry SV. Troponin T: genetics, properties and function. J Muscle Res Cell Motil 1998; 19: 575-602.
50. Perry SV. Troponin I: inhibitor or facilitator. Mol Cell Biochem 1999; 190: 9-32.
51. Johnston JJ, Kelley RI, Crawford TO, et al. A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet 2000; 67: 814-821.
52. Ferreiro A, Monnier N, Romero NB, et al. A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene. Ann Neurol 2002; 51: 750-759.
53. Scacheri PC, Hoffman EP, Fratkin JD, et al. A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology 2000; 55: 1689-1696.
54. Wallgren-Pettersson C, Laing NG. 109th ENMC International Workshop: 5th workshop on nemaline myopathy, 11th-13th October 2002, Naarden, The Netherlands. Neuromuscul Disord 2003; 13: 501-507.
55. Roth SM, Walsh S. Myostatin: a therapeutic target for skeletal muscle wasting. Curr Opin Clin Nutr Metab Care 2004; 7 259-263.
56. Bogdanovich S, Perkins KJ, Krag TO, Khurana TS. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med 2004; 82: 102-115.
57. Haslett JN, Sanoudou D, Kho AT, et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A 2002; 99: 15 000-15 005.
58. Greenberg SA, Sanoudou D, Haslett JN, et al. Molecular profiles of inflammatory myopathies. Neurology 2002; 59: 1170-1182.
59. Sparrow J, Reedy M, Ball E, et al. Functional and ultrastructural effects of a missense mutation in the indirect flight muscle-specific actin gene of Drosophila melanogaster. J Mol Biol 1991; 222: 963-982.
60. An HS, Mogami K. Isolation of 88F actin mutants of Drosophila melanogaster and possible alterations in the mutant actin structures. J Mol Biol 1996; 260: 492-505.